Surgical glue refers to a synthetic or biological material used after traumatic injuries and surgeries for preventing liquid or air leakage in wounds. It is a special kind of medical sealant or adhesive that facilitates closing and healing of wounds and are capable of replacing staples and sutures in healing incisions and minor cuts. At present, the increasing incidence of plastic surgeries is creating a huge requirement for surgical glue worldwide. As per the International Society of Aesthetic Plastic Surgery (ISAPS), 1,795,551 breast augmentation, 1,704,786 liposuction, 1,259,839 eyelid surgery, 924,031 abdominoplasty, and 821,890 rhinoplasty procedures were performed in 2019.
Moreover, the booming geriatric population will fuel the surgical glue market at a CAGR of 10.6% during the forecast period. The market revenue stood at $3,810.5 million in 2017 and it is expected to reach $6,936.5 million by 2023. The World Population Ageing 2020 report estimates that the population of people aged 65 years and above will surge from 727 million in 2020 to 1.5 billion by 2050. Elderly people are highly susceptible to cancer, diabetes, cardiovascular diseases (CVDs), and neurological disorders, which require surgeries to close incisions.
According to P&S Intelligence, North America will consume the highest volume of surgical glue in the foreseeable future, due to the huge investments being made in the research and development (R&D) of medical adhesives and increasing number of surgeries being performed in the region. For instance, the American Society of Plastic Surgeons (ASPS) reveals that 6,878,486 reconstructive surgical procedures, 13,281,235 cosmetic minimally-invasive procedures, and 2,314,720 cosmetic surgical procedures were performed in the U.S. in 2020.
Thus, the rising incidence of plastic surgeries, burgeoning aging population, and soaring cases of chronic diseases will augment the usage of surgical glues in the forthcoming years.
Source: www.psmarketresearch.com
